Abstract
Case: An 8-year-old girl was diagnosed with osteosarcoma of the distal femur. She underwent chemotherapy and wide resection with implantation of a noninvasive electromagnetic expandable distal femur prosthesis. Ninety-three days after chemotherapy, she developed anthracycline-induced cardiomyopathy with heart failure for which a ventricular assist device was placed. Device compatibility was tested, and she was successfully lengthened. Conclusion: Expandable prostheses allow limb length maintenance in skeletally immature patients who undergo limb salvage. Chemotherapy for osteosarcoma involves anthracyclines with a dose-dependent side effect of cardiotoxicity. Patients can be successfully and safely lengthened with expandable electromagnetic prostheses with in situ ventricular assist devices.
Original language | English (US) |
---|---|
Article number | e20.00270 |
Journal | JBJS case connector |
Volume | 11 |
Issue number | 2 |
DOIs | |
State | Published - Apr 27 2021 |
Bibliographical note
Funding Information:N ote : No funding was received in support of this work. The authors declare that they have no competing interest. All authors read and approved the final manuscript.
Publisher Copyright:
COPYRIGHT © 2021 BY THE JOURNAL OF BONE AND JOINT SURGERY, INCORPORATED
Keywords
- Endoprosthesis
- Noninvasive
- Prosthesis
- VAD
- Ventricular assist device
PubMed: MeSH publication types
- Journal Article
- Case Reports